These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7779780

  • 21. Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.
    Klezovitch O, Edelstein C, Scanu AM.
    J Clin Invest; 1996 Jul 01; 98(1):185-91. PubMed ID: 8690792
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of fibrinolysis by lipoprotein(a).
    Anglés-Cano E, de la Peña Díaz A, Loyau S.
    Ann N Y Acad Sci; 2001 Jul 01; 936():261-75. PubMed ID: 11460483
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100.
    Koschinsky ML, Côté GP, Gabel B, van der Hoek YY.
    J Biol Chem; 1993 Sep 15; 268(26):19819-25. PubMed ID: 8366120
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Interaction of fibrin(ogen) with apolipoprotein(a): further characterization and identification of a novel lysine-dependent apolipoprotein(a)-binding site within the gamma chain 287-411 region.
    Tsurupa G, Yakovlev S, Pechik I, Lamanuzzi LB, Anglés-Cano E, Medved L.
    Biochemistry; 2006 Sep 05; 45(35):10624-32. PubMed ID: 16939214
    [Abstract] [Full Text] [Related]

  • 29. Structural elucidation of the N- and O-glycans of human apolipoprotein(a): role of o-glycans in conferring protease resistance.
    Garner B, Merry AH, Royle L, Harvey DJ, Rudd PM, Thillet J.
    J Biol Chem; 2001 Jun 22; 276(25):22200-8. PubMed ID: 11294842
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Lysine-binding heterogeneity of Lp(a): consequences for fibrin binding and inhibition of plasminogen activation.
    Bas Leerink C, Duif PF, Gimpel JA, Kortlandt W, Bouma BN, van Rijn HJ.
    Thromb Haemost; 1992 Aug 03; 68(2):185-8. PubMed ID: 1412165
    [Abstract] [Full Text] [Related]

  • 34. Isolation and characterization of the two major apoproteins in human lipoprotein [a].
    Gaubatz JW, Chari MV, Nava ML, Guyton JR, Morrisett JD.
    J Lipid Res; 1987 Jan 03; 28(1):69-79. PubMed ID: 2951469
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Functional analysis of the chimpanzee and human apo(a) promoter sequences: identification of sequence variations responsible for elevated transcriptional activity in chimpanzee.
    Huby T, Dachet C, Lawn RM, Wickings J, Chapman MJ, Thillet J.
    J Biol Chem; 2001 Jun 22; 276(25):22209-14. PubMed ID: 11301336
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
    Sangrar W, Koschinsky ML.
    Biochem Cell Biol; 2000 Jun 22; 78(4):519-25. PubMed ID: 11012092
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.